Genometrix to Validate Osteoporosis SNPs in Japanese Study | GenomeWeb

NEW YORK, May 9 - Genometrix will work with Nippon Medical School in Tokyo to validate osteoporosis-related SNPs in the Japanese population, the company said Wednesday.

In the study, researchers at Nippon Medical School will screen 100 SNPs against 1,200 clinical patient samples using Genometrix's VistaMorph genotyping technology. They will then use the osteoporosis-related SNPs they find to develop a microarray-based diagnostic and treatment system using Genometrix’s VistaArray microarrays. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.